Estonia regulates e-money under the Payment Institutions and E-Money Institutions Act (Makseasutuste ja e-raha asutuste seadus, the MERAS), and Finantsinspektsioon (formally the Financial Supervision and Resolution Authority) is the single point of contact for both authorisation and ongoing supervision. The same regulator now also delivers Estonia’s MiCA framework, which matters for any acquirer planning to layer e-money tokens on top of an existing EMI permission.

The headline draw for buyers is reach. An Estonian EMI passports into all 26 other EU member states under EMD2 notification, so a single share-purchase moves you from outside the EU to a counter that issues e-money to customers in Helsinki, Madrid, and Dublin without re-authorisation. The Estonian regulator is small enough to be reachable and large enough to have written guidance at the level of detail acquirers need (business plan, governance map, IT and security descriptions, AML programme, capital evidence, fit-and-proper packs for board and key managers).

One contrarian note. The e-residency programme draws acquirers who assume the substance test is light. It isn’t. The MERAS minimum still applies, the management board still has to seat at least two members in Estonia, and “located in Estonia” reads as physical presence rather than postal forwarding. Acquisition is faster than a de-novo file, but the substance bar is the same one.

Live entities authorised under MERAS, with safeguarding accounts already operational at an Estonian or wider Eurozone credit institution. Each comes pre-screened on three diligence gates that derail more share-purchase deals than price ever does: continuity of the EUR safeguarding relationship after the cap-table change, an AML programme that survives the regulator’s first post-closing inspection without remediation orders, and FTE retention — the MLRO and at least one Estonian-resident board member willing to stay on through the change-of-control assessment.

We do not name specific entities on public pages. The book moves week to week as files clear our standing checks or close. Acquirers who send an acquisition brief receive a profile sheet and indicative term sheet under NDA.

• Single-side mandate. We never advise the seller on the same trade. The fee comes from the buyer, the loyalty sits with the buyer, and there is no incentive to push closing prices toward the centre of a bid-ask range that suits both parties equally.
• Pre-vetted on the gates that actually fail deals. Banking continuity, AML programme readiness, and fit-and-proper coverage of the inheriting board are the three points where Estonian deals stall. We screen on these before the entity reaches the acquirer’s brief.
• Built for expedited closings. Our workstream runs share-purchase diligence and the qualifying-holding notification in parallel, not in sequence. The Estonian regulator’s two-track expectation (substance review plus standard SPA conditions precedent) is the workflow we structure around.